Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
Submitted by
admin
on May 15, 2025 - 10:40pm
Source:
Benzinga
News Tags:
Eli Lilly
Rznomics
hearing loss
RNA therapeutics
Headline:
Eli Lilly Collaborates With Rznomics On Hearing Loss Treatment In $1.3 Billion Pact
snippet:
Eli Lilly’s total deal value with Rznomics could exceed $1.3 billion, plus royalties.
Rznomics will lead early-stage research; Lilly to handle development and sales.
Do Not Allow Advertisers to Use My Personal information
